ProShare Advisors LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$51,000
-50.0%
18,904
-18.9%
0.00%
Q4 2021$102,000
-9.7%
23,322
+4.9%
0.00%
Q3 2021$113,000
-37.2%
22,232
-22.0%
0.00%
-100.0%
Q2 2021$180,000
-8.2%
28,508
+12.2%
0.00%0.0%
Q1 2021$196,000
+75.0%
25,408
+48.3%
0.00%
Q4 2020$112,000
+30.2%
17,138
+32.0%
0.00%
Q3 2020$86,000
-23.2%
12,981
-3.7%
0.00%
-100.0%
Q2 2020$112,000
-15.2%
13,475
-15.4%
0.00%0.0%
Q4 2019$132,000
+3.1%
15,930
-8.3%
0.00%0.0%
Q3 2019$128,000
-36.3%
17,365
-3.2%
0.00%0.0%
Q2 2019$201,000
-7.4%
17,940
-11.0%
0.00%0.0%
Q1 2019$217,000
-27.9%
20,163
+1.1%
0.00%
-50.0%
Q4 2018$301,000
-31.6%
19,943
-16.1%
0.00%
-33.3%
Q3 2018$440,000
-10.2%
23,783
+10.9%
0.00%0.0%
Q2 2018$490,000
-19.8%
21,451
-0.1%
0.00%
-25.0%
Q1 2018$611,000
+15.7%
21,472
-14.1%
0.00%0.0%
Q4 2017$528,00025,0060.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
BVF INC/IL 1,877,148$13,853,0001.46%
Congress Park Capital LLC 167,811$1,238,0001.04%
Perceptive Advisors 3,253,923$24,014,0000.65%
RTW INVESTMENTS, LP 990,463$7,310,0000.44%
Spark Investment Management LLC 337,164$2,488,0000.32%
Exane Asset Management 54,065$399,000,0000.31%
DAFNA Capital Management LLC 100,000$738,0000.28%
HARBOURVEST PARTNERS LLC 79,193$584,0000.24%
WELD CAPITAL MANAGEMENT LLC 86,363$637,0000.12%
GSA CAPITAL PARTNERS LLP 77,997$576,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders